BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2016 2:15:00 PM | Browse: 508 | Download: 540
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 21716
Country/Territory United States
2015-09-08 08:22
Peer-Review Started
2015-09-08 13:24
To Make the First Decision
2015-10-27 11:01
Return for Revision
2015-11-06 15:58
2015-11-15 02:27
Second Decision
2016-01-20 16:33
Accepted by Journal Editor-in-Chief
2016-01-21 08:11
Accepted by Company Editor-in-Chief
2016-01-29 17:30
Articles in Press
2016-01-29 17:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-21 10:23
Publish the Manuscript Online
2016-03-30 14:14
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Molecular therapeutics in pancreas cancer
Manuscript Source Invited Manuscript
All Author List Vignesh Narayanan and Colin D Weekes
Funding Agency and Grant Number
Corresponding author Colin D Weekes, MD, PhD, Division of Medical Oncology, Department of Medicine, Developmental Therapeutics Program, University of Colorado Cancer Center, University of Colorado School of Medicine, 12801 E. 17th Avenue, Aurora, CO 80045, United States. colin.weekes@ucdenver.edu
Keywords Pancreas neoplasm; Vaccines; Targeted therapy; Immunotherapy; Kirsten rat sarcoma oncogene
Core Tip The treatment of pancreas ductal adenocarcinoma is in an exciting phase due to a tremendous surge in knowledge regarding the molecular mechanisms that underlie pancreas cancer that has fueled interest in devising novel strategies to target signal transduction factors downstream to kirsten rat sarcoma oncogene, desmoplastic tumor stroma and cancer stem cells. Furthermore, immunotherapy by utilizing vaccines and immune checkpoint inhibitors is gaining momentum. Alluring results from studies evaluating molecularly targeted therapies have not only proven the feasibility of this approach but are also indicative of a paradigm shift in management of pancreatic cancer in the near future.
Publish Date 2016-03-30 14:14
Citation Narayanan V, Weekes CD. Molecular therapeutics in pancreas cancer. World J Gastrointest Oncol 2016; 8(4): 366-379
Url http://www.wjgnet.com/1948-5204/full/v8/i4/366.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i4.366
Full Article (PDF) WJGO-8-366.pdf
Full Article (Word) WJGO-8-366.doc
Manuscript File 21716-Review.docx
Answering Reviewers 21716-Answering reviewers.pdf
Audio Core Tip 21716-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 21716-Conflict-of-interest statement.pdf
Copyright License Agreement 21716-Copyright assignment.pdf
Peer-review Report 21716-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 21716-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 21716-Scientific misconduct check.pdf
Scientific Editor Work List 21716-Scientific editor work list.pdf